A recent survey reveals that older Americans are increasingly proactive about Alzheimer's, with 79% wanting to know if they have the disease before symptoms arise. Many would opt for a blood test and are open to new drug treatments.
A new blood test developed by neuroscientists can reveal whether Alzheimer's is affecting a patient's memory, providing crucial insights for early diagnosis and treatment. This innovation could transform how we understand and address Alzheimer's disease.
A groundbreaking study reveals that a biologic drug may delay Alzheimer's symptoms in individuals with genetic predispositions. With promising results, researchers emphasize the importance of continued funding for further investigation.
